Cytovation
@cytovation.com
The power of immunotherapy can be directed at multiple diseases – from benign tumors to malignant cancers. CyPep-1 is a first-in-class tumor membrane targeted immunotherapy for the treatment of solid tumors.
Cytovation's Company Logos
Cytovation's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#525E70
Comet
82, 94, 112
216, 15, 38
27, 16, 0, 56
#94C2D1
Half Baked
148, 194, 209
195, 40, 70
29, 7, 0, 18
#112857
Blue Zodiac
17, 40, 87
220, 67, 20
80, 54, 0, 66
About Cytovation
Cytovation ASA is at the forefront of innovative cancer treatment with our groundbreaking technology. Our approach targets cancer cells by creating pores in the plasma membrane, which releases cancer-specific antigens to the immune system, promoting an inflammatory microenvironment, and triggering a tumor-specific immune response through in situ vaccination. Our flagship technology, CyPep-1, specifically disrupts cancer cell membranes, releasing tumor neoantigens to the immune system and inhibiting the beta-catenin pathway to impede tumor growth.
This dual-action peptide not only targets cancer cells but also stimulates the immune system for a systemic, cancer-specific response. Cytovation ASA is dedicated to revolutionizing cancer treatment and paving the way for more effective and targeted therapies. Join us in our mission to combat cancer and improve patient outcomes
Company type
Privately Held
Year founded
2015
Company size
2-10 employees
